Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?
↗
Today 12:35 EDT
Via
The Motley Fool
Tickers
LLY
VKTX
Exposures
Product Safety
3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
↗
Today 10:35 EDT
Via
MarketBeat
Tickers
AAPG
IVA
LRMR
Exposures
Product Safety
Kaplan Fox Notifies Investors of Beta Bionics, Inc. (NASDAQ: BBNX) of the Lead Plaintiff Deadline on November 3, 2026
October 09, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Why Natera (NTRA) Stock Is Up Today
October 09, 2026
Via
StockStory
Tickers
AMZN
NTRA
PYPL
Exposures
Product Safety
Teva Wins FDA Approval for Monthly Schizophrenia Injectable WELTRUZA
↗
October 09, 2026
Via
MarketBeat
Tickers
TEVA
Exposures
Product Safety
Greensboro Pest Control Requirements For SQF Audits: Compliance Guide Released
October 09, 2026
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
October 09, 2026
Via
NewMediaWire
Tickers
BAC
MDLN
Exposures
Product Safety
Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval
↗
October 09, 2026
Via
Investor's Business Daily
Exposures
Product Safety
Kaplan Fox is Investigating Whether Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Made Misleading Statements to Investors
October 09, 2026
Via
NewMediaWire
Tickers
FULC
Exposures
Product Safety
Theralase(R) to Present at ThinkEquity Conference
October 09, 2026
Via
Newsfile
Tickers
TLTFF
TSX-V:TLT
Exposures
Product Safety
No Psychedelic Belongs on the Market, CCHR Tells Regulators
October 09, 2026
Via
24-7 Press Release
Exposures
Product Safety
Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026
October 08, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
2 Growth Stocks to Buy in October
↗
October 08, 2026
Via
The Motley Fool
Tickers
AZN
GRAL
LLY
MRK
PFE
VEEV
Exposures
Product Safety
Only 20 Stocks Are Holding Up the Market: 3 Bargains Outside AI
↗
October 08, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
CASY
JOBY
LLY
NOW
NVO
WMT
Exposures
Artificial Intelligence
Product Safety
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) on November 3, 2026
October 08, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
↗
October 07, 2026
Via
The Motley Fool
Tickers
AXSM
MRNA
Exposures
Product Safety
Capricor Highlights Two-Year Deramiocel Data as FDA Decision Nears
↗
October 07, 2026
Via
MarketBeat
Tickers
CAPR
Exposures
Product Safety
Kaplan Fox Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) - Deadline is November 3, 2026
October 07, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
SS Innovations International Inc. (NASDAQ: SSII) Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
October 07, 2026
Via
Investor Brand Network
Tickers
SSII
Exposures
Product Safety
4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch
October 07, 2026
Via
AB Newswire
Topics
Animal Testing
Artificial Intelligence
Tickers
IGC
RIME
TOPP
VIVS
Exposures
Animal Testing
Artificial Intelligence
Product Safety
Why Are Neogen (NEOG) Shares Soaring Today
October 07, 2026
Via
StockStory
Topics
Earnings
Tickers
NEOG
Exposures
Financial
Product Safety
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
October 07, 2026
Via
NewMediaWire
Tickers
BAC
MDLN
Exposures
Product Safety
Diabetes Cell Therapy Enters a New Era as Billion-Dollar Market Opportunity Takes Shape
October 07, 2026
Via
FinancialNewsMedia
Tickers
AVAI
BMEA
LABT
TNDM
Exposures
Product Safety
Gout Treatments Need A Better Option: XORTX Therapeutics Is Betting XORLO Is It, Targets New Drug Application With FDA Next Year
October 07, 2026
Via
NewMediaWire
Tickers
XRTX
Exposures
Product Safety
Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of a Pending Securities Investigation
October 07, 2026
Via
NewMediaWire
Tickers
FULC
Exposures
Product Safety
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026 for a Leadership Role
October 06, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Food Plant Cleaning Services Expands National Coverage for Specialized Sanitation and Disinfection
October 06, 2026
Via
Press Advantage
Exposures
Product Safety
Five-Minute Vagus Nerve Health Assessment for Stressed Adults Announced
October 06, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Raises Approximately $5.6 Million in PIPE Financing
October 06, 2026
Via
Investor Brand Network
Tickers
TELO
Exposures
Product Safety
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
October 06, 2026
Via
Investor Brand Network
Tickers
QNTM
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.